Biosplice Therapeutics

About:

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.

Website: https://www.biosplice.com

Top Investors: Sands Capital Ventures, Vickers Venture Partners, Eventide, aMoon Fund, Verition Fund Management

Description:

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology. Samumed adopted a fresh operating philosophy from the beginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.